Trials / Completed
CompletedNCT05782816
Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor
Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: A Randomized Control Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 170 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question\[s\] it aims to answer are: * Does a high dose oxytocin infusion protocol affect length of induction to delivery interval? * Does a high dose oxytocin infusion protocol affect mode of delivery? * Does a high dose oxytocin infusion protocol affect maternal and neonatal outcomes? Participants will be randomized to either low- or high-dose oxytocin groups: * The low dose group will receive an infusion to start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. The maximum rate of infusion is 40 milli-units/min. * The high dose group will receive an infusion to start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin (Low dose) | Low dose oxytocin |
| DRUG | Oxytocin (High dose) | High dose oxytocin |
Timeline
- Start date
- 2023-04-17
- Primary completion
- 2024-12-31
- Completion
- 2025-06-24
- First posted
- 2023-03-24
- Last updated
- 2026-01-09
- Results posted
- 2026-01-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05782816. Inclusion in this directory is not an endorsement.